Press release: PIONEER Big Data for Better Outcomes joins forces with the European Association of Urology’s UroEvidenceHub to combat prostate cancer and other urological diseases
Read morePIONEER – Big Data in Prostate Cancer project continues as PIONEER+ and will be integrated into the EAU`s UroEvidenceHub initiative as the hub for prostate cancer research and support. Amsterdam, The Netherlands, 31st October 2023 – The European funded...
PIONEER News Flash – The PIONEER Big Data Platform for Prostate Cancer
Read moreA unique infrastructure in Europe that enables a collaborative research environment to improve prostate cancer diagnosis, treatment, and care for patients and their families. Read all about it at: PIONEER Big Data Platform
Welcome! PIONEER News Flash – Lantheus joins the PIONEER Big Data consortium to strengthen the AI enabled PSMA imaging biomarker.
Read morePIONEER – The European Network of Excellence for Big Data in Prostate Cancer – welcomes Lantheus as a new external data and technology provider to the consortium! PIONEER (Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big...
EHDS stakeholder meeting with EU officials
Read more6 September 2023, Brussels – PIONEER as part of a multi-stakeholder group consisting of 32 European patient organisations, medical associations, research organisations, data collaborations and industry associations met EU officials, including MEP Tomislav Sokol, Co-Rapporteur, as well as several...
PIONEER and the Chinese University of Hong Kong Started a Big Data Collaboration to Fight Prostate Cancer Worldwide
Read moreThe European funded prostate cancer project PIONEER – Big Data in Prostate Cancer and the Faculty of Medicine of The Chinese University of Hong Kong have signed a data sharing agreement to ensure more data diversity and a better...
Joint Statement: health organisations define EHDS’ opt out required for life saving research
Read moreOn 6 June, PIONEER joined together with 31 other health stakeholders to share views on specific recommendations for a potential opt-out mechanism in the future EHDS. These organisations and initiatives have joined forces because they all share the view...
Contact us here
PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
